B F Scharschmidt

Current status of artificial hepatic support systems.

P D Berk, J F Martin, B F Scharschmidt, 1976, Progress in liver diseases.

Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.

J L Merritt, B F Scharschmidt, S. Cederbaum, 2012, Molecular genetics and metabolism.

Chance, concurrence, and clustering. Analysis of reviewers' recommendations on 1,000 submissions to the Journal of Clinical Investigation.

B F Scharschmidt, P Bacchetti, A DeAmicis, 1994, The Journal of clinical investigation.